ABSTRACT
【Objective】 To investigate the willingness of whole blood donors to donate apheresis platelets and analyze its influencing factors. 【Methods】 A total of 400 whole blood donors from Kunshan Blood Station and Leshan Blood Station from January to May, 2023 were surveyed by random sampling, and their willingness to donate apheresis platelets were analyzed by univariate analysis and binary logistic regression analysis. 【Results】 A total of 386 valid questionnaires were collected, with a recovery rate of 96.5%. Among the 386 whole blood donors, 177 were willing to donate apheresis platelets, accounting for 45.9%. Univariate analysis showed that gender, age, education level, blood donation times, average blood donation volume, adverse reactions to blood donation, understanding of platelets, and family members' attitude towards blood donation were the main factors affecting the willingness of whole blood donors to donate platelets, and binary logistic regression analysis showed that gender, age, blood donation times, average blood donation volume, understanding of platelets and family members' attitude towards blood donation were the main factors. 【Conclusion】 Targeted recruitment of whole blood donors should be conducted to recruit more apheresis platelet donors, so as to meet clinical demand of apheresis platelets.
ABSTRACT
Atrial fibrillation(AF)is a prevalent arrhythmia in elderly patients.Such patients often have comorbidities and are subjected to polypharmacy, which may lower medication compliance and increase the risk of bleeding and cardiovascular events.These factors may also affect the efficacy of anticoagulant therapy.According to research, non-vitamin K antagonistic oral anticoagulants like Rivaroxaban, Apixaban, and Dabigatran are a safer and more effective option for anticoagulant therapy in elderly patients with atrial fibrillation compared to warfarin.Studying the impact of polypharmacy on anticoagulant therapy in elderly patients with atrial fibrillation can aid in the development of personalized treatment strategies and improve the prognosis of aged patients.